National Health Act 1953 Amendment determination under paragraph 98C(1)(b) conditions (No. PB 37 of 2011) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 37 of 2011
Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953
I, FELICITY McNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.
Dated 16 May 2011
FELICITY McNEILL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
Amendment determination — conditions
1 Commencement
This instrument commences on 1 June 2011.
2 Amendment of the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1 Amendments
[1] Schedule 1, after entry for Mycophenolic Acid with Water – Purified BP
insert in the columns in the order indicated:
| Phenoxymethylpenicillin with Water – Purified BP | Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL |
[2] Schedule 4, omit entry for Memantine
[3] Schedule 4, entry for Risedronic Acid and Calcium
insert as next entry in the column headed “Form”:
| Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate) |
[4] Schedule 4, entry for Risedronic acid and calcium with colecalciferol
insert as next entry in the column headed “Form”:
| Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms |
[5] Schedule 4, omit entry for Sulfacetamide
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0